You finally have investor interest. A couple of angels like the idea, one says “We usually do SAFEs,” another asks if you’re open to a convertible note, and suddenly you’re deep in legal blog posts at ...
In the realm of biotech and pharmaceuticals, fundraising often plays a pivotal role in driving innovation and progress. Biotech and pharmaceutical companies, whether private startups or established ...
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ: OMCL) (“Omnicell”) today announced that it intends to offer, subject to market conditions and other factors, $150.0 million aggregate ...
Akamai Technologies (AKAM) announced on Monday that it proposes to offer $1.3B in aggregate principal amount of 0% convertible senior notes due 2030 and $1.3B in aggregate principal amount of 0% ...
MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today ...
NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced its intention to offer, subject to market and other conditions, $1 billion aggregate principal amount ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results